Next Article in Journal
Tumor Cell-Autonomous Pro-Metastatic Activities of PD-L1 in Human Breast Cancer Are Mediated by PD-L1-S283 and Chemokine Axes
Next Article in Special Issue
Rationale for Combing Stereotactic Body Radiation Therapy with Immune Checkpoint Inhibitors in Medically Inoperable Early-Stage Non-Small Cell Lung Cancer
Previous Article in Journal
Fate of Surgical Patients with Small Nonfunctioning Pancreatic Neuroendocrine Tumors: An International Study Using Multi-Institutional Registries
Previous Article in Special Issue
Exploring the Evolving Scope of Neoadjuvant Immunotherapy in NSCLC
 
 

Order Article Reprints

Journal: Cancers, 2022
Volume: 14
Number: 1041

Article: Real-World Time on Treatment with First-Line Pembrolizumab Monotherapy for Advanced NSCLC with PD-L1 Expression ≥ 50%: 3-Year Follow-Up Data
Authors: by Vamsidhar Velcheti, Xiaohan Hu, Yeran Li, Hazem El-Osta, M. Catherine Pietanza and Thomas Burke
Link: https://www.mdpi.com/2072-6694/14/4/1041

MDPI offers high quality article reprints with convenient shipping to destinations worldwide. Each reprint features a 270 gsm bright white cover and 105 gsm premium white paper, bound with two stitches for durability and printed in full color. The cover design is customized to your article and designed to be complimentary to the journal.

Order Cost and Details

Shipping Address

Billing Address

Notes or Comments

Validate and Place Order

The order must be prepaid after it is placed

req denotes required fields.
Back to TopTop